Company Filing History:
Years Active: 2012
Title: Dana Raε Benesh: Innovator in Opioid Receptor Antagonists
Introduction
Dana Raε Benesh is a notable inventor based in Westfield, IN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that serve as opioid receptor antagonists. His work is aimed at addressing obesity, a growing health concern worldwide.
Latest Patents
Dana Raε Benesh holds a patent for his invention titled "4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity." This patent describes compounds that are useful in treating obesity by acting on opioid receptors. The compounds are characterized by specific formulae that include various structural components, allowing for the formation of indolinyl, indolyl, or benzimidazole rings.
Career Highlights
Dana Raε Benesh is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development in medicine. His work at Eli Lilly has allowed him to contribute to important advancements in drug development, particularly in the area of obesity treatment.
Collaborations
Dana has collaborated with Maria-Jesus Blanco-Pillado, a fellow researcher, to further enhance the scope and impact of their work in the pharmaceutical industry.
Conclusion
Dana Raε Benesh's contributions to the field of pharmacology, particularly through his patent on opioid receptor antagonists, highlight his role as an innovator in addressing obesity. His work continues to influence the development of effective treatments in this critical area of health.